Brian Rittenhouse
Professor of Health Economics and Program Director for Boston
he/him
School
School of Pharmacy
Department
School of Pharmacy
Office Location
Matricaria 4006H
Boston
Office Phone Office Phone: 617.732.2168
About
Before returning to academia, Dr. Rittenhouse was a VP at Genzyme, heading their global health outcomes and strategic pricing. His time at Genzyme followed 14 years of similarly focused positions at Schering-Plough, Amgen, Pharmacia, J&J, and Ciba-Geigy. Dr. Rittenhouse has worked closely with business units, affiliates and outside academics to optimize product positioning and to develop strategic plans for documenting product value to support product global pricing, reimbursement, and access/uptake. He has been on full-time faculty at UNC Chapel Hill, Université de Montreal (Rhône-Poulenc Rorer Chair, Pharmacoeconomics), as well as being a Visiting Professor, Institute for Health Economics and Policy (IHEP) in Tokyo. Dr. Rittenhouse is the author of numerous peer-reviewed journal articles, served for six years on the editorial board for Medical Decision Making and is currently an Associate Editor, Value in Health.
Education
- BA, Economics, Oberlin College
- MS, Economics, University of Wisconsin - Madison
- PhD, Economics, University of Wisconsin - Madison
Research Interests
- Improper use of methods in published Cost-Effectiveness Analyses
- Methods in Cost-Effectiveness research
- Challenges of parameter estimation in studies with non-random sampling and/or when data are missing
- Cost-Effectiveness studies in the Diabetes Prevention Program Newborn
- screening for rare diseases
Featured Affiliations
Associate Editor, Value in Health (a leading journal in health economics)
WebsiteMember, International Society for Pharmaco-economics and Outcomes Research (ISPOR)
WebsiteMember, Boston Chapter, ISPOR (former president of this organization)
WebsiteEducation
- BA, Economics, Oberlin College
- MS, Economics, University of Wisconsin - Madison
- PhD, Economics, University of Wisconsin - Madison
Research Interests
- Improper use of methods in published Cost-Effectiveness Analyses
- Methods in Cost-Effectiveness research
- Challenges of parameter estimation in studies with non-random sampling and/or when data are missing
- Cost-Effectiveness studies in the Diabetes Prevention Program Newborn
- screening for rare diseases